CTOs on the Move

ImprimisRx

www.imprimisrx.com

 
ImprimisRx® is a pharmaceutical company dedicated to delivering high-quality and innovative medicines to physicians and patients at affordable prices. We are pioneering a new commercial pathway in the pharmaceutical industry, using compounding pharmacies for the formulation and distribution of high-quality formulations that are supported by the clinical experience of physicians and their patients. We offer proprietary compounded ophthalmic formulations. All of our innovative drug formulations are born from the clinical experience of physicians and pharmacist formulators. We are focused on people, and believe our unique business model provides us with the opportunity to address unmet patient needs while delivering high quality ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.imprimisrx.com
  • 12264 El Camino Real Suite 350
    San Diego, CA USA 92130
  • Phone: 858.264.2082

Executives

Name Title Contact Details
James Pham
 Senior Director Information Technology Profile
Feliks Dushatsky
 Director of Information Technology Operations Profile

Similar Companies

Acadian Companies

Acadian Companies is a Lafayette, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Matheny Medical and Educational Center

Matheny Medical and Educational Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Peapack, NJ. To find more information about Matheny Medical and Educational Center, please visit www.matheny.org

Bruce Valentine, DDS

Bruce Valentine, DDS is a Modesto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Research Diets

Research Diets is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.